SCHEMBL6537348

SCHEMBL6537348

O=C(Nc1cccc2c(OC(=O)c3c(Cl)cccc3Cl)ncnc12)c1c(Cl)cccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYK2 P29597 8/20 0.44
JAK2 O60674 7/20 0.44
JAK1 P23458 6/20 0.44
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
POLB P06746 1/20 0.42
CYP3A4 P08684 1/20 0.40
KDR P35968 1/20 0.39
PABPC1 P11940 1/20 0.39
EIF4H Q15056 1/20 0.39
LMNA P02545 1/20 0.38
CRHBP P24387 1/20 0.38
HTT P42858 1/20 0.38
CRHR2 Q13324 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CDK9 P50750 1/20 0.37
JAK3 P52333 1/20 0.37
SLC16A3 O15427 1/20 0.37
ABL1 P00519 1/20 0.36
SRC P12931 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8475500 0.87 MEN1 (0.45) TYK2JAK2JAK1MEN1KMT2A
SCHEMBL6537462 0.81 TYK2 (0.49) TYK2JAK2JAK1MEN1KMT2A
SCHEMBL6537904 0.80 RAB9A (0.48) TYK2JAK2JAK1MEN1KMT2A
SCHEMBL6538073 0.76 TYK2 (0.56) TYK2JAK2JAK1MEN1KMT2A
SCHEMBL6537749 0.74 POLB (0.45) TYK2JAK2JAK1MEN1KMT2A
SCHEMBL6537937 0.74 PTGES (0.41) TYK2JAK2JAK1MEN1KMT2A
SCHEMBL6537365 0.74 TYK2 (0.46) TYK2JAK2JAK1MEN1KMT2A
SCHEMBL6537345 0.73 TYK2 (0.47) TYK2JAK2JAK1MEN1KMT2A
SCHEMBL6538084 0.73 TYK2 (0.53) TYK2JAK2JAK1MEN1KMT2A
SCHEMBL6538163 0.73 NR4A2 (0.57) TYK2JAK2JAK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed